Background
The FiGARO (FFR versus iFR in Assessment of Hemodynamic Lesion Significance, and an Explanation of Their Discrepancies) trial is a prospective registry searching for predictors of fractional flow reserve/instantaneous wave‐free ratio (FFR/iFR) discrepancy.
Methods and Results
FFR/iFR were analyzed using a Verrata wire, and coronary flow reserve was analyzed using a Combomap machine (both Philips‐Volcano). The risk polymorphisms for endothelial nitric oxide synthase and for heme oxygenase‐1 were analyzed. In total, 1884 FFR/iFR measurements from 1564 patients were included. The FFR/iFR discrepancy occurred in 393 measurements (20.9%): FFRp (positive)/iFRn (negative) type (264 lesions, 14.0%) and FFRn/iFRp (129 lesions, 6.8%) type. Coronary flow reserve was measured in 343 lesions, correlating better with iFR (R=0.56,
P
<0.0001) than FFR (R=0.36,
P
<0.0001). The coronary flow reserve value in FFRp/iFRn lesions (2.24±0.7) was significantly higher compared with both FFRp/iFRp (1.39±0.36), and FFRn/iFRn lesions (1.8±0.64,
P
<0.0001). Multivariable logistic regression analysis confirmed (1) sex, age, and lesion location in the right coronary artery as predictors for FFRp/iFRn discrepancy; and (2) hemoglobin level, smoking, and renal insufficiency as predictors for FFRn/iFRp discrepancy. The FFRn/iFRp type of discrepancy was significantly more frequent in patients with both risk types of polymorphisms (endothelial nitric oxide synthase
r
+heme oxygenase‐1
r
): 8 patients (24.2%) compared with FFRp/iFRn type of discrepancy: 2 patients (5.9%),
P
=0.03.
Conclusions
Predictors for FFRp/iFRn discrepancy were sex, age, and location in the right coronary artery. Predictors for FFRn/iFRp were hemoglobin level, smoking, and renal insufficiency. The risk type of polymorphism in endothelial nitric oxide synthase and heme oxygenase‐1 genes was more frequently found in patients with FFRn/iFRp type of discrepancy.
Registration
URL:
https://clinicaltrials.gov
; Unique identifier: NCT03033810.
The prediction of coronary vessel involvement by means of noninvasive tests is one of the fundamental objectives of preventive cardiology. This review describes the current possibilities of coronary vessel involvement prediction by means of ultrasonographic examination of carotid arteries, analysis of polymorphisms in the genes encoding enzymes responsible for production of nitric oxide and carbon monoxide and assessment of levels of certain proinfl ammatory cytokines. In the presented work these noninvasive markers are correlated with the extent of coronary vessel involvement as assessed by coronary angiography, intravascular ultrasound and virtual histology (Fig. 5, Ref. 40).
An interface based on electromyographic (EMG) signals is considered one of the central fields in human-machine interface (HCI) research with broad practical use. This paper presents the recognition of 13 individual finger movements based on the time-frequency representation of EMG signals via spectrograms. A deep learning algorithm, namely a convolutional neural network (CNN), is used to extract features and classify them. Two approaches to EMG data representations are investigated: different window segmentation lengths and reduction of the measured channels. The overall highest accuracy of the classification reaches 95.5% for a segment length of 300 ms. The average accuracy attains more than 90% by reducing channels from four to three.
Heme oxygenase‐1 (HO‐1) is a stress protein that degrades heme to biliverdin, iron, and carbon monoxide (CO). A (GT)n dinucleotide repeat polymorphism in the HO‐1 promoter has been shown to modulate HO‐1 gene expression. Short (<25) GT repeats are associated with HO‐1 up‐regulation. Multiple sclerosis (MS) is an autoimmune disorder resulting in CNS demyelination and neurodegeneration. HO‐1 or exposure to its end product CO counters autoimmune neuroinflammation and might have therapeutic potential for the treatment of MS. In this study, we investigated the association of the HO‐1 promoter (GT)n repeat polymorphism in 291 patients with MS. We used data from previous studies as a control group. We compared the frequencies of short (<25) repeat (class S) and long (≥25) repeat (class L) alleles. No significant difference between these two groups was found. Thus, the (GT)n dinucleotide repeat polymorphism in the HO‐1 promoter is not associated with MS. Comparison of the course of MS disease in patient groups homoallelic for either S/S or L/L may add yield differences in the expression of the diseases symptoms, suggesting that therapeutic intervention with HO‐1 inducers may be possible.Supported by Grants: IGA MZ 1A8713‐5, GAUK 109/2006, MSMT 0021620806.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.